PIRS Pieris Pharmaceuticals Inc

About PIRS

Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of Anticalin-based drugs. Its pipeline includes immuno-oncology, respiratory, and anemia and other disease areas. The company was founded by Claus Schalper and Arne Skerra in 2001 and is headquartered in Boston, MA.
43

Bearish Sentiment

How do you feel about PIRS?

Advertisement|Remove ads.